se of nalbuphine drug as an additive with 0.5 percent levobupivacaine for upper limb orthopedic surgery in ultrasound guided supraclavicular block.
Phase 4
Not yet recruiting
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/07/055741
- Lead Sponsor
- School of Medical Science And Research And Sharda Hospital, Greater Noida
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients undergoing elective upper limb surgery.
2. Age between 18 to 65 years.
3. ASA physical status class 1 and 2
Exclusion Criteria
1. Patients with a history of allergy or hypersensitivity to either local anaesthetic or opioid drugs.
2. Pregnancy
3. Patients with coagulation disorders
4. Local infection at the site of injection
5. Patients who are taking any antipsychotics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method